These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29520688)

  • 1. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
    Kitab B; Kohara M; Tsukiyama-Kohara K
    Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate Antiviral Immunity against Dengue Virus.
    Makhluf H; Shresta S
    Crit Rev Immunol; 2015; 35(3):253-60. PubMed ID: 26559229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus vaccine development.
    Yauch LE; Shresta S
    Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines licensed and in clinical trials for the prevention of dengue.
    Torresi J; Ebert G; Pellegrini M
    Hum Vaccin Immunother; 2017 May; 13(5):1059-1072. PubMed ID: 28281864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity to dengue virus infection and subversion of antiviral responses.
    Green AM; Beatty PR; Hadjilaou A; Harris E
    J Mol Biol; 2014 Mar; 426(6):1148-60. PubMed ID: 24316047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines and immunization strategies for dengue prevention.
    Liu Y; Liu J; Cheng G
    Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of dengue virus infection and disease.
    Yauch LE; Shresta S
    Antiviral Res; 2008 Nov; 80(2):87-93. PubMed ID: 18619493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
    Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
    BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in dengue vaccine development.
    Wei J; Chen H; An J
    Virol Sin; 2014 Dec; 29(6):353-63. PubMed ID: 25547681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.
    Aguiar M; Stollenwerk N; Halstead SB
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005179. PubMed ID: 28002420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to dengue virus and prospects for a vaccine.
    Murphy BR; Whitehead SS
    Annu Rev Immunol; 2011; 29():587-619. PubMed ID: 21219187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a recombinant, chimeric tetravalent dengue vaccine candidate.
    Osorio JE; Partidos CD; Wallace D; Stinchcomb DT
    Vaccine; 2015 Dec; 33(50):7112-20. PubMed ID: 26585500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue vaccines: Are they safe for travelers?
    Halstead SB; Aguiar M
    Travel Med Infect Dis; 2016; 14(4):378-83. PubMed ID: 27343438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
    Liang H; Lee M; Jin X
    Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the contribution of cellular immunity to dengue disease pathogenesis.
    Mathew A; Rothman AL
    Immunol Rev; 2008 Oct; 225():300-13. PubMed ID: 18837790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection.
    Kayesh MEH; Kitab B; Sanada T; Hayasaka D; Morita K; Kohara M; Tsukiyama-Kohara K
    Infect Genet Evol; 2017 Jul; 51():203-210. PubMed ID: 28392469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
    Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
    J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
    Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
    mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue mouse models for evaluating pathogenesis and countermeasures.
    Chen RE; Diamond MS
    Curr Opin Virol; 2020 Aug; 43():50-58. PubMed ID: 32950933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.